Jie Wang

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Analysis of factors associated with substandard nutrition in critically ill patients and the effect of applying enteral nutrition nursing model based on evidence-based medicine: A retrospective observational study

  Medicine · 2025-12-12

• Bilateral primary breast angiosarcoma: A rare case and therapeutic insight

  Asian Journal of Surgery · 2025-12-12

• Modified Bidirectional Projection Technique for Spherical Fuzzy MAGDM and Applications to Demand Evaluation for Public Sports Services for the Elderly in Rural Areas

  International Journal of Fuzzy Systems · 2025-12-10

• Study of the blood–brain barrier-penetrating KRAS G12C inhibitor JMKX1899 in KRAS G12C-mutated NSCLC with brain metastases

  Journal of the National Cancer Center · 2025-12-05 · 1 citations

• Long-term outcomes and clinical features of stage III non-small-cell lung cancer harboring ALK rearrangements: a multicenter retrospective study of 176 patients

  Journal of the National Cancer Center · 2025-11-27

• Isomerization-engineered ESIPT-based probe for dynamic glutathione imaging in liver injury

  Journal of Molecular Structure · 2025-11-21

• Tumor-associated macrophages (CD68+) as a potential prognostic biomarker for PD-1 inhibitor response in relapsed/refractory classical Hodgkin lymphoma

  Blood · 2025-11-03

• Unraveling the active ingredients and molecular mechanisms of Qinghua Changyan granule against irritable bowel syndrome with diarrhea: Effects on gut microbiota and glutamine transport via an integrative approach combining UHPLC-MS/MS and experimental verification

  Fitoterapia · 2025-10-30 · 1 citations

• Anti‐PD‐1 Nanobody‐Armored MSLN CAR‐T Therapy for Malignant Mesothelioma: Preclinical and Clinical Studies

  Advanced Science · 2025-10-24 · 4 citations

• Long-term outcomes of postoperative radiotherapy for patients with pIIIA-N2 non-small-cell lung cancer after complete resection and adjuvant chemotherapy (PORT-C): a single-centre, randomized, phase 3 trial

  EClinicalMedicine · 2025-10-17

• P2.10.14 Individualized Neoantigen Therapy With Unusual Radiotherapy Enhancement (iNATURE) a Phase II Randomized Study

  Journal of Thoracic Oncology · 2025-10-01

• PL02.09 Aumolertinib plus Chemotherapy for NSCLC with EGFR and Concomitant Tumor Suppressor Genes (ACROSS 2): Phase III study

  Journal of Thoracic Oncology · 2025-10-01

• First-Line Tislelizumab Plus Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer: PD-L1 ≥ 50% Subgroup Analysis from the RATIONALE-304 Trial

  Oncology and Therapy · 2025-09-14

• Burden of chemotherapy-induced myelosuppression (CIM) in Chinese patients with extensive-stage small cell lung cancer (ES-SCLC): A retrospective real-world study

  Chinese Medical Journal - Pulmonary and Critical Care Medicine · 2025-09-01

• WITHDRAWN: 1865P Association between immune-related adverse events and clinical outcomes in non-small cell lung cancer patients treated with chemo-immunotherapy: A post hoc analysis of the phase III choice-01 trial

  Annals of Oncology · 2025-09-01

• 2135P FS-1502 in patients with HER2 expression, locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (GC/GEJ): An open-label, multicenter, phase II study

  Annals of Oncology · 2025-09-01

• Dual polarization-independent quasi-BICs enabled by out-of-plane symmetry breaking in nanodisk tetramer metasurface

  Optics Letters · 2025-08-28 · 6 citations

• Dissecting the genetic architecture of yield-related traits by QTL mapping in maize

  Frontiers in Plant Science · 2025-08-15

• Supplementary Table S1 from Phase I/II Study of Tifcemalimab, an Anti–B- and T-lymphocyte Attenuator Antibody, in Combination with Toripalimab in Previously Treated Advanced Lung Cancer

  2025-07-15

• Supplementary Figure S5 from Phase I/II Study of Tifcemalimab, an Anti–B- and T-lymphocyte Attenuator Antibody, in Combination with Toripalimab in Previously Treated Advanced Lung CancerPreprint

  2025-07-15